Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Intravenous Thrombolysis in Acute Ischemic Stroke Patients With Recent Ingestion of Factor Xa-inhibitors Trial (SIFT)

NCT06878066 is registered in ClinicalTrials.gov with Guri Hagberg as lead sponsor.

NCT NCT06878066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06878066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Intravenous Thrombolysis in Acute Ischemic Stroke Patients With Recent Ingestion of Factor Xa-inhibitors Trial (SIFT)
Lead sponsor
Guri Hagberg
Phase
Phase 3
Overall status
Recruiting
Start date
March 14, 2025
Completion date
December 31, 2037
Enrollment
300 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke, anticoagulant therapy, bleeding in the brain, factor xa inhibitor, hemorrhagic transformation due to acute stroke, intracranial hemorrhages, ischemic stroke, stroke, stroke (in patients with atrial fibrillation)